Related Experiment Video
Updated: Aug 11, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Pax-5 is a key regulator of the B cell-restricted expression of the CD23a isoform
Ioana Visan1, Martin Goller, Ingolf Berberich
1Medizinische Poliklinik, University of Würzburg, Würzburg, Germany.
Insights
Pax-5, a B-cell transcription factor, drives B-cell-specific CD23a isoform expression. This finding reveals Pax-5 as a key regulator for CD23a, impacting inflammatory responses.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Human CD23, the low-affinity IgE receptor, is a B cell marker implicated in inflammation.
- Two isoforms, CD23a and CD23b, exist, differing in cytoplasmic domains and expression patterns.
- CD23b is induced by IL-4 in B and myeloid cells, while CD23a is B-cell restricted.
Purpose of the Study:
- To investigate the role of Pax-5 transcription factor in regulating the B-cell-specific CD23a isoform expression.
- To elucidate the molecular mechanisms underlying CD23a promoter activation by Pax-5.
Main Methods:
- Analysis of the CD23a promoter for Pax-5 binding sites using electrophoretic mobility shift assays.
- Site-directed mutagenesis to assess the functional importance of the identified Pax-5 binding site.
- Reporter gene assays in 293 cells to measure promoter activity upon Pax-5 expression.
- Ectopic expression of Pax-5 in U-937 monocytic cells to evaluate CD23a induction.
Main Results:
- A functional Pax-5 binding site was identified in the CD23a promoter.
- Pax-5 binding to this site was confirmed via electrophoretic mobility shift assays and abrogated by mutation.
- Pax-5 significantly activated the CD23a core promoter in 293 cells.
- Ectopic Pax-5 expression in U-937 cells induced CD23a expression under specific stimulation conditions.
Conclusions:
- Pax-5 is a critical regulator of B-cell-specific CD23a isoform expression.
- The findings highlight Pax-5's role in controlling CD23a transcription, potentially influencing B cell differentiation and inflammatory processes.
Abstract:
Human CD23 (the low affinity IgE receptor) is a B cell differentiation marker involved in inflammatory responses. Two isoforms (CD23a and CD23b) are known, which differ only in their cytoplasmic domain. Whereas CD23b expression is specifically induced by IL-4 on B cells and cells of the myeloid lineage, CD23a expression is restricted to B cells. Each isoform is regulated by its own promoter. Pax-5 is a B-cell-restricted transcription factor with an essential role in early and late B cell development. Analyses of the CD23a promoter revealed a Pax-5-binding site, which can compete a high affinity Pax-5-binding site or directly bind Pax-5 protein in electrophoretic mobility shift assays. Introducing mutations into this site abrogates the binding. Expression of Pax-5 in 293 cells resulted in a seven- to tenfold activation of a CD23a core promoter construct. Most importantly, ectopic expression of Pax-5 in the monocytic cell line U-937, which regularly expresses only the CD23b isoform, led to CD23a expression after stimulation with IL-4 and PMA. Our results suggest that Pax-5 is a key regulator of the B-cell-restricted expression of the CD23a isoform.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Cell Specific Gene Expression
Master Transcription Regulators
Abnormal Proliferation
Cell Specific Gene Expression
Regulation of Expression at Multiple Steps

